AD01 Follow up Extension Visit

Affiris

Status: Completed

Conditions: Alzheimer´s Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT01225809

AFF003E

Details and patient eligibility

About

Patients who were vaccinated with AFFITOPE AD01 during AFFiRiS001 will undergo a long-term follow-up period to get more information regarding the safety profile of AFFITOPE AD01.

Enrollment: 17 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Written informed consent signed and dated by the patient or the patient's legal representative and the caregiver.
• Patients having participated in AFFiRiS 001 and AFF003 and having received ≥1 vaccination with AFFITOPE AD01
• Availability of a partner/caregiver knowing the patient

Exclusion criteria

• Patients having received no vaccination with AFFITOPE AD01
• History of questionable compliance to visit schedule

Trial design

17 participants in 1 patient group

AD01with or without adjuvant

Description:

Patients who have received at least one immunization of AD01 with or without adjuvant during AFF001